Show Notes
This episode's guest speaker is the Clinical Director of the Fatty Liver Disease Program and Assistant Professor of Medicine at the Yale School of Medicine- Dr. Albert Do. Dr. Do completed his undergraduate studies with Bachelor’s Degrees in Molecular and Cell Biology and Psychology at the University of California at Berkeley, and a medical doctorate and Master’s in Public Health Epidemiology at Boston University. He completed his residency and fellowship training at Yale University. He has expertise and interest in gastroenterology, hepatology, obesity medicine, and metabolic health. He is particularly interested in all forms of fatty liver disease, including nonalcoholic fatty liver disease and associated obesity, as well as alcohol-associated fatty liver disease, which are significant public health problems. Being board-certified in obesity and lifestyle medicine further informs his interest and skills in metabolic health.
The episode covers information pertaining to liver diseases that lead to cirrhosis, obesity medication, drugs, research, differential diagnosis of hepatic diseases, the obesity epidemic, and more!
This article discusses how even drugs like Acetaminophen (Tylenol) impact the liver: Hinson, J. A., Roberts, D. W., & James, L. P. (2010). Mechanisms of acetaminophen-induced liver necrosis. Handbook of experimental pharmacology, (196), 369–405. https://doi.org/10.1007/978-3-642-00663-0_12
